Medicis Pharmaceutical Stock Price, News & Analysis (NYSE:MRX)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Medicis Pharmaceutical (NYSE:MRX)

Medicis Pharmaceutical logoMedicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta).

Receive MRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Generic Pharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNYSE:MRX
CUSIPN/A
Phone+1-212-5992000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Medicis Pharmaceutical (NYSE:MRX) Frequently Asked Questions

What is Medicis Pharmaceutical's stock symbol?

Medicis Pharmaceutical trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRX."

Who are some of Medicis Pharmaceutical's key competitors?

Who are Medicis Pharmaceutical's key executives?

Medicis Pharmaceutical's management team includes the folowing people:

  • Robert Roswell Chai-Onn, Executive Vice President, General Counsel, Secretary, Director (Age 44)
  • Howard Bradley Schiller, Officer, Director (Age 53)
  • Ryan Weldon, Officer, Director

How do I buy Medicis Pharmaceutical stock?

Shares of Medicis Pharmaceutical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Medicis Pharmaceutical?

Medicis Pharmaceutical's mailing address is 8125 N Hayden Rd, SCOTTSDALE, AZ 85258-2463, United States. The healthcare company can be reached via phone at +1-212-5992000.


MarketBeat Community Rating for Medicis Pharmaceutical (MRX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  97 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  211
MarketBeat's community ratings are surveys of what our community members think about Medicis Pharmaceutical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Medicis Pharmaceutical (NYSE:MRX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Medicis Pharmaceutical (NYSE:MRX) Earnings History and Estimates Chart

Earnings by Quarter for Medicis Pharmaceutical (NYSE:MRX)

Medicis Pharmaceutical (NYSE MRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2012$0.46$0.52ViewN/AView Earnings Details
5/8/2012$0.42$0.60ViewN/AView Earnings Details
11/8/2011$0.61$0.56ViewN/AView Earnings Details
8/8/2011$0.64$0.64ViewN/AView Earnings Details
5/5/2011$0.49$0.50ViewN/AView Earnings Details
2/25/2011$0.60$0.60ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Medicis Pharmaceutical (NYSE:MRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Medicis Pharmaceutical (NYSE:MRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Medicis Pharmaceutical (NYSE MRX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Medicis Pharmaceutical (NYSE MRX) News Headlines

Source:
DateHeadline
Medicis Pharmaceutical Corp (MRX) versus Depomed (DEPO) Critical SurveyMedicis Pharmaceutical Corp (MRX) versus Depomed (DEPO) Critical Survey
www.americanbankingnews.com - November 23 at 9:14 PM
Head to Head Comparison: Depomed (DEPO) and Medicis Pharmaceutical Corp (MRX)Head to Head Comparison: Depomed (DEPO) and Medicis Pharmaceutical Corp (MRX)
www.americanbankingnews.com - November 8 at 5:31 PM

SEC Filings

Medicis Pharmaceutical (NYSE:MRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Medicis Pharmaceutical (NYSE:MRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Medicis Pharmaceutical (NYSE MRX) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.